• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒样颗粒:一种递送癌症抗原以引发抗肿瘤免疫反应的纳米平台。

Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response.

作者信息

Ning Weisen, Yan Sheng, Song Yongyao, Xu Hanning, Zhang Jinling, Wang Xiaomei

机构信息

School of Medicine, Wuhan University of Science and Technology, Wuhan, Hubei, China.

Department of Oncology, Wuhan Fourth Hospital, Wuhan Orthopedic Hospital, Wuhan, Hubei, China.

出版信息

Front Immunol. 2025 Jan 7;15:1504124. doi: 10.3389/fimmu.2024.1504124. eCollection 2024.

DOI:10.3389/fimmu.2024.1504124
PMID:39840069
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11747419/
Abstract

Virus-like particles (VLPs), as a unique form of nanocarrier, predominantly encompass hollow protein shells that exhibit analogous morphology and structure to naturally occurring viruses, yet devoid of genetic material. VLPs are considered safe, easily modifiable, and stable, making them suitable for preparation in various expression systems. They serve as precise biological instruments with broad applications in the field of medical biology. Leveraging their unique structural attributes and facile modification capabilities, VLPs can serve as an effective platform for the delivery of tumor antigens, thereby stimulating the immune system and facilitating the eradication of tumor cells.

摘要

病毒样颗粒(VLPs)作为一种独特形式的纳米载体,主要由中空蛋白壳组成,这些蛋白壳在形态和结构上与天然存在的病毒相似,但不含遗传物质。VLPs被认为是安全的、易于修饰的和稳定的,这使得它们适合在各种表达系统中制备。它们是精确的生物工具,在医学生物学领域有着广泛的应用。利用其独特的结构特性和易于修饰的能力,VLPs可以作为递送肿瘤抗原的有效平台,从而刺激免疫系统并促进肿瘤细胞的根除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d7/11747419/4c54b97aba8f/fimmu-15-1504124-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d7/11747419/c28e8c5b3a25/fimmu-15-1504124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d7/11747419/2a69de065c5f/fimmu-15-1504124-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d7/11747419/4c54b97aba8f/fimmu-15-1504124-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d7/11747419/c28e8c5b3a25/fimmu-15-1504124-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d7/11747419/2a69de065c5f/fimmu-15-1504124-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/17d7/11747419/4c54b97aba8f/fimmu-15-1504124-g003.jpg

相似文献

1
Virus-like particle: a nano-platform that delivers cancer antigens to elicit an anti-tumor immune response.病毒样颗粒:一种递送癌症抗原以引发抗肿瘤免疫反应的纳米平台。
Front Immunol. 2025 Jan 7;15:1504124. doi: 10.3389/fimmu.2024.1504124. eCollection 2024.
2
Influenza virus-like particles engineered by protein transfer with tumor-associated antigens induces protective antitumor immunity.通过与肿瘤相关抗原进行蛋白质转移工程改造的流感病毒样颗粒可诱导保护性抗肿瘤免疫。
Biotechnol Bioeng. 2015 Jun;112(6):1102-10. doi: 10.1002/bit.25537. Epub 2015 Apr 17.
3
VLPs and particle strategies for cancer vaccines.病毒样颗粒和粒子策略在癌症疫苗中的应用。
Expert Rev Vaccines. 2013 Oct;12(10):1173-93. doi: 10.1586/14760584.2013.836909.
4
B19-VLPs as an effective delivery system for tumour antigens to induce humoral and cellular immune responses against triple negative breast cancer.B19-VLPs 作为一种有效的肿瘤抗原传递系统,可诱导针对三阴性乳腺癌的体液和细胞免疫应答。
Immunol Lett. 2021 Nov;239:77-87. doi: 10.1016/j.imlet.2021.09.002. Epub 2021 Sep 9.
5
The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference.第五届病毒样颗粒和纳米颗粒疫苗(VLPNPV)会议。
Expert Rev Vaccines. 2019 Jan;18(1):1-3. doi: 10.1080/14760584.2019.1557522. Epub 2018 Dec 13.
6
Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines.病毒样颗粒作为癌症疫苗的免疫原性平台。
Viruses. 2020 Apr 27;12(5):488. doi: 10.3390/v12050488.
7
Tumor-Associated Myeloid Cells Selective Delivery of a Therapeutic Tumor Nano-Vaccine for Overcoming Immune Barriers for Effective and Long-Term Cancer Immunotherapy.肿瘤相关髓系细胞递呈治疗性肿瘤纳米疫苗以克服免疫障碍实现有效和长期的癌症免疫治疗
Adv Healthc Mater. 2024 Oct;13(26):e2401416. doi: 10.1002/adhm.202401416. Epub 2024 Jun 11.
8
Vaccination with nanoparticles combined with micro-adjuvants protects against cancer.纳米颗粒与微佐剂联合疫苗接种可预防癌症。
J Immunother Cancer. 2019 Apr 26;7(1):114. doi: 10.1186/s40425-019-0587-z.
9
Bovine papillomavirus prostate cancer antigen virus-like particle vaccines are efficacious in advanced cancers in the TRAMP mouse spontaneous prostate cancer model.牛乳头瘤病毒前列腺癌抗原病毒样颗粒疫苗在 TRAMP 小鼠自发性前列腺癌模型的晚期癌症中有效。
Cancer Immunol Immunother. 2020 Apr;69(4):641-651. doi: 10.1007/s00262-020-02493-z. Epub 2020 Feb 4.
10
Virus-like antigen display for cancer vaccine development, what is the potential?用于癌症疫苗开发的病毒样抗原展示,其潜力如何?
Expert Rev Vaccines. 2018 Apr;17(4):285-288. doi: 10.1080/14760584.2018.1455505. Epub 2018 Mar 30.

本文引用的文献

1
Targeting lymph nodes for enhanced cancer vaccination: From nanotechnology to tissue engineering.靶向淋巴结以增强癌症疫苗接种:从纳米技术到组织工程
Mater Today Bio. 2024 Apr 26;26:101068. doi: 10.1016/j.mtbio.2024.101068. eCollection 2024 Jun.
2
Nanocapsules Comprised of Purified Protein: Construction and Applications in Vaccine Research.由纯化蛋白组成的纳米胶囊:构建及其在疫苗研究中的应用
Vaccines (Basel). 2024 Apr 12;12(4):410. doi: 10.3390/vaccines12040410.
3
Polymeric Nanoparticles for Drug Delivery.高分子纳米粒药物递送系统
Chem Rev. 2024 May 8;124(9):5505-5616. doi: 10.1021/acs.chemrev.3c00705. Epub 2024 Apr 16.
4
Advancing nanotechnology for neoantigen-based cancer theranostics.推进基于新生抗原的癌症诊治的纳米技术。
Chem Soc Rev. 2024 Apr 2;53(7):3224-3252. doi: 10.1039/d3cs00162h.
5
Vaccine development: Current trends and technologies.疫苗研发:当前趋势与技术。
Life Sci. 2024 Jan 1;336:122331. doi: 10.1016/j.lfs.2023.122331. Epub 2023 Dec 7.
6
Nano-drug delivery system targeting tumor microenvironment: A prospective strategy for melanoma treatment.纳米药物递送系统靶向肿瘤微环境:治疗黑色素瘤的有前景策略。
Cancer Lett. 2023 Oct 10;574:216397. doi: 10.1016/j.canlet.2023.216397. Epub 2023 Sep 18.
7
Membrane-localized neoantigens predict the efficacy of cancer immunotherapy.膜定位的新抗原预测癌症免疫疗法的疗效。
Cell Rep Med. 2023 Aug 15;4(8):101145. doi: 10.1016/j.xcrm.2023.101145. Epub 2023 Aug 7.
8
Lipid Nanoparticle (LNP) Enables mRNA Delivery for Cancer Therapy.脂质纳米颗粒 (LNP) 可实现癌症治疗的 mRNA 递送。
Adv Mater. 2023 Dec;35(51):e2303261. doi: 10.1002/adma.202303261. Epub 2023 Nov 1.
9
Stimulation of the immune system by a tumor antigen-bearing adenovirus-inspired VLP allows control of melanoma growth.携带肿瘤抗原的腺病毒启发的病毒样颗粒对免疫系统的刺激可控制黑色素瘤的生长。
Mol Ther Methods Clin Dev. 2022 Dec 7;28:76-89. doi: 10.1016/j.omtm.2022.12.003. eCollection 2023 Mar 9.
10
Neoantigens: promising targets for cancer therapy.肿瘤新抗原:癌症治疗的有前途的靶点。
Signal Transduct Target Ther. 2023 Jan 6;8(1):9. doi: 10.1038/s41392-022-01270-x.